Search

Displaying results 9571 - 9580 of 10000 in total
  1. Drug

    Ciprefadol

    go.drugbank.com/drugs/DB20896
    Experimental

    The usage of the INN stem '-adol/-adol-' in the name indicates that Ciprefadol is a analgesic. Ciprefadol has a monoisotopic molecular weight of 285.21 Da.

  2. Drug

    Premazepam

    go.drugbank.com/drugs/DB21027
    Experimental

    The usage of the INN stem '-azepam' in the name indicates that Premazepam is a diazepam derivative. Premazepam has a monoisotopic molecular weight of 253.12 Da.

  3. Drug

    Elfazepam

    go.drugbank.com/drugs/DB21142
    Experimental

    The usage of the INN stem '-azepam' in the name indicates that Elfazepam is a diazepam derivative. Elfazepam has a monoisotopic molecular weight of 408.07 Da.

  4. Drug

    Maroxepin

    go.drugbank.com/drugs/DB21379
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Maroxepin is a tricyclic compound. Maroxepin has a monoisotopic molecular weight of 277.15 Da.

  5. Drug

    Reclazepam

    go.drugbank.com/drugs/DB21411
    Experimental

    The usage of the INN stem '-azepam' in the name indicates that Reclazepam is a diazepam derivative. Reclazepam has a monoisotopic molecular weight of 373.04 Da.

  6. Drug

    Metoxepin

    go.drugbank.com/drugs/DB21433
    Experimental

    The usage of the INN stem '-oxepin' in the name indicates that Metoxepin is a tricyclic compound. Metoxepin has a monoisotopic molecular weight of 322.17 Da.

  7. Drug

    Rizedisben

    go.drugbank.com/drugs/DB21610
    Investigational

    Rizedisben is under investigation in clinical trial NCT04983862 (Fluorescent Imaging of Nerves with Illuminare-1 During Surgery). Rizedisben has a monoisotopic molecular weight of 519.22 Da.

  8. Drug

    Davelizomib

    go.drugbank.com/drugs/DB21660
    Experimental

    The usage of the INN stem '-zomib' in the name indicates that Davelizomib is a proteasome inhibitor. Davelizomib has a monoisotopic molecular weight of 481.18 Da.

  9. Drug

    Apazunersen

    go.drugbank.com/drugs/DB16981
    Investigational

    Apazunersen is an antisense oligonucleotide designed to target and inhibit the expression of UBE3A-AS. It is being investigated for the treatment of Angelman Syndrome.[L46772]

  10. Drug

    Girentuximab I-124

    go.drugbank.com/drugs/DB15025
    Investigational

    Girentuximab I-124 is under investigation in clinical trial NCT01762592 (REDECT 2: REnal Masses: Pivotal Trial to DEteCT Clear Cell Renal Cell Carcinoma With PET/CT).